Eurocine Vaccines is a pharmaceutical company. Today, the company develops vaccines for the treatment of influenza. The vaccine may be used by both adults and children and is applied through nasal drops rather than needle sticks. The products are sold under separate trademarks, and the largest business is found in the Nordic market, where research is carried out in cooperation with other companies in the industry. The head office is located in Solna.

Quotes for Eurocine Vaccines AB

Right Now

+/-
0.001
%
0,46%
Latest
0.218
High
0.219
Low
0.199
Volume
1 246 511
Turnover (SEK)
265 072
Value (MSEK)
46,3

Board

CEO

  • Hans Arwidsson

Chairman Of The Board

  • Pierre A. Morgon

Board

  • Hans Arwidsson
  • Jan Sandström
  • Pär Thuresson

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 20,67 20,67 2019-06-30
VisMederi Srl 6,43 6,43 2019-05-27
Nordnet Pensionsförsäkring 4,24 4,24 2019-06-30
Niclas Falk 1,78 1,78 2019-06-30
Hans Arwidsson 1,22 1,22 2018-12-07
Aaro Pellervo Nurkkala 1,18 1,18 2019-06-30
BRL Invest AB 1,13 1,13 2019-06-30
Göran Erlandsson 1,03 1,03 2019-06-30
Nordea Liv & Pension 0,99 0,99 2019-06-30
Pär Thuresson 0,95 0,95 2018-12-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Inquiry Financial